1. Efficacy and safety of a recombinant factor IX (Bax326)1 in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open‐label, uncontrolled, multicentre, phase III study. (3rd April 2014) Authors: Windyga, J.; Lissitchkov, T.; Stasyshyn, O.; Mamonov, V.; Ghandehari, H.; Chapman, M.; Fritsch, S.; Wong, W.‐Y.; Pavlova, B. G.; Abbuehl, B. E. Journal: Haemophilia Issue: Volume 20:Number 5(2014:Sep.) Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of a recombinant factor IX (Bax326)1 in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open‐label, uncontrolled, multicentre, phase III study. (3rd April 2014) Authors: Windyga, J.; Lissitchkov, T.; Stasyshyn, O.; Mamonov, V.; Ghandehari, H.; Chapman, M.; Fritsch, S.; Wong, W.‐Y.; Pavlova, B. G.; Abbuehl, B. E. Journal: Haemophilia Issue: Volume 20:Number 5(2014:Sep.) Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Enhanced figure of merit of poly(9, 9‐di‐n‐octylfluorene‐alt‐benzothiadiazole) and SWCNT thermoelectric composites by doping with FeCl3. Issue 5 (23rd August 2018) Authors: Zhou, X.; Pan, C.; Liang, A.; Wang, L.; Wan, T.; Yang, G.; Gao, C.; Wong, W.‐Y. Journal: Journal of applied polymer science Issue: Volume 136:Issue 5(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia B. (9th July 2013) Authors: Windyga, J.; Lissitchkov, T.; Stasyshyn, O.; Mamonov, V.; Rusen, L.; Lamas, J. L.; Oh, M.‐S.; Chapman, M.; Fritsch, S.; Pavlova, B. G.; Wong, W.‐Y.; Abbuehl, B. E. Journal: Haemophilia Issue: Volume 20:Number 1(2014:Jan.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Randomized comparison of prophylaxis and on‐demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors. (1st August 2013) Authors: Antunes, S. V.; Tangada, S.; Stasyshyn, O.; Mamonov, V.; Phillips, J.; Guzman‐Becerra, N.; Grigorian, A.; Ewenstein, B.; Wong, W.‐Y. Journal: Haemophilia Issue: Volume 20:Number 1(2014:Jan.) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗